Bioavailability evidence — ADMETatlas
Skip to content
ADMET
atlas
peptide evidence atlas
Search peptide, product, endpoint, sequence…
K
Home
Browse
Developability
Resources
About
Search atlas
K
Home
Browse
Evidence
·
Exposure / Absorption
Reported
Bioavailability evidence
ATLXM0045268
Home
Evidence
Peptides
Products
Evidence
Context signals
Descriptors
Developability
Profile
Comparator
Resources
Manual
Explanations
Statistics
Download
License
About
Bioavailability
Measurement
ATLXM0045268
Peptide
ATLPC0009237
→
Measured material
Peptide backbone
Endpoint
Bioavailability
→
ADMET domain
Exposure / Absorption
Value
Observation
Because exenatide is administerd subcutaneously, the bioavailability is 1.
Evidence role
Reported: reviewed reported observation that should not be pooled as a comparable value yet
Assay / model
Not specified
Condition
Route: SC · 21 · Exenatide · exact product name match · field mismatch
Scientific source
PepTherDia
Open source
Manual
Explanations
Statistics
Download
About
Stack
© 2026 ADMETatlas, an academic peptide ADMET evidence atlas.
